21 Similarly, a prospective case series of 14 patients with both HS and obesity treated with liraglutide 3 mg for 3 months demonstrated reductions in BMI, waist circumference, systemic inflammatory markers like CRP, homocysteine and plasma cortisol, and DLQI
10.1016/j.biocel.2014.01.014 Int
The studies featured follow-up periods ranging from 6 to 12 months and measured outcomes including on-treatment weight loss, HbA1c changes, and heterogeneous cardiovascular events (e.g., all-cause mortality, myocardial infarction, and stroke)
Bo qun ni kh ro, thong mt, trnh nh nng chiu vo
36 If high enough suspicion of IEM, consider starting IV sodium benzoacetate/sodium phenylacetate (Ammonul) and L-arginine to help with nitrogen excretion
Carole Wagner, RN Hi, Im Carole